Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Cognitive Dysfunction × Metformin × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 8 Melanoma 3 Urinary Bladder Neoplasms 2 Prostatic Neoplasms 2 Obesity 2 Neoplasms 2 Infertility 2 Glioblastoma 2 Adenocarcinoma Of Esophagus 2 Uterine Cervical Neoplasms 1 TP53 Y220C Mutation 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Ewing 1 Sarcoma 1 Prostate Cancer Recurrent 1 Progression-Free Survival 1 Preleukemia 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Osteosarcoma 1 Non-Muscle Invasive Bladder Neoplasms 1 Metabolic Diseases 1 Medulloblastoma 1 Leukoplakia, Oral 1 Leukemia, Myeloid, Acute 1 Insulin Resistance 1 Hypoxia 1 Hyperandrogenism 1 Glioma 1 Esophageal Neoplasms 1

Interventions

mazdutide 1 lithium sulfate 1 lime 1 fasudil 1 blueberry extract 1 Walking 1 Waiting Lists 1 Transcranial Magnetic Stimulation 1 Transcranial Direct Current Stimulation 1 Therapeutics 1 Tablets 1 Radiotherapy 1 Radiosurgery 1 Patient Reported Outcome Measures 1 Organization and Administration 1 Neuropsychological Tests 1 Modafinil 1 Methods 1 Metformin 1 Mental Status and Dementia Tests 1 Memantine 1 Low-Level Light Therapy 1 Lithium 1 Infliximab 1 Drug Therapy 1 Data Collection 1 Cognitive Behavioral Therapy 1 Chemoradiotherapy 1 Accidental Falls 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05230758 2026-01-22

Met Med Can

The Hospital for Sick Children

Phase 3 Recruiting

Medulloblastoma, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon ⚡